Stoke Therapeutics, Inc. (STOK): SCHEDULE 13G filed Sep 30, 2026

Form type

SCHEDULE 13G

Filing date

Sep 30, 2026

Accession number

0000921895-26-002685

Filer

Stoke Therapeutics, Inc. (CIK 1623526)